Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis sells its RNAi cast-offs from Alnylam in $35M fire sale to Arrowhead
Novartis sells its RNAi cast-offs from Alnylam in $35M fire sale to Arrowhead
Novartis sells its RNAi cast-offs from Alnylam in $35M fire sale to Arrowhead
Submitted by
admin
on March 5, 2015 - 8:21am
Source:
Fierce Biotech
News Tags:
Novartis
Alnylam
RNAi
Arrowhead Research
Headline:
Novartis sells its RNAi cast-offs from Alnylam in $35M fire sale to Arrowhead
Do Not Allow Advertisers to Use My Personal information
